Metraipolis › archive › dc_af6d8d6181ea

Emerging biologic modalities for targeted protein degradation — Europe PMC PMID:41651431

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41651431
DOI
10.1016/j.jbc.2026.111248
License (as archived)
solo-consultazione
Archived
2026-11-06T03:16:42.277Z
SHA-256 of the archived text
106c4f627537354433ae38f6efca7d83b424e9370a4146dfba9d08bd82d64966
Stable URL of this page
https://metraipolis.com/documento/dc_af6d8d6181ea

How to cite

Emerging biologic modalities for targeted protein degradation — Europe PMC PMID:41651431 — Europe PMC (en), https://europepmc.org/article/MED/41651431 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_af6d8d6181ea (Metraipolis archive dc_af6d8d6181ea, sha256 106c4f627537354433ae38f6efca7d83b424e9370a4146dfba9d08bd82d64966)
BibTeX
@misc{dcaf6d8d6181ea,
  title = {Emerging biologic modalities for targeted protein degradation — Europe PMC PMID:41651431},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41651431},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_af6d8d6181ea; sha256 106c4f627537354433ae38f6efca7d83b424e9370a4146dfba9d08bd82d64966},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41651431. Agents can read the archived copy with the MCP tool read_document.